MENU
+Compare
DVAX
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$9.83
Change
+$0.03 (+0.31%)
Capitalization
1.15B

DVAX Dynavax Technologies Corp Forecast, Technical & Fundamental Analysis

Dynavax Technologies Corp is a biopharmaceutical company... Show more

Industry: #Biotechnology
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DVAX with price predictions
Oct 17, 2025

Aroon Indicator for DVAX shows an upward move is likely

DVAX's Aroon Indicator triggered a bullish signal on October 17, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 200 similar instances where the Aroon Indicator showed a similar pattern. In of the 200 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DVAX's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DVAX advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DVAX as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DVAX turned negative on October 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

DVAX moved below its 50-day moving average on October 10, 2025 date and that indicates a change from an upward trend to a downward trend.

DVAX broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DVAX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.333) is normal, around the industry mean (17.681). P/E Ratio (54.600) is within average values for comparable stocks, (72.923). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.078). DVAX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (3.965) is also within normal values, averaging (46.505).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DVAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DVAX is expected to report earnings to fall 9.21% to 12 cents per share on October 30

Dynavax Technologies Corp DVAX Stock Earnings Reports
Q3'25
Est.
$0.13
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.81
Q4'24
Beat
by $0.01
Q3'24
Est.
$0.12
The last earnings report on August 07 showed earnings per share of 14 cents, beating the estimate of 10 cents. With 1.15M shares outstanding, the current market capitalization sits at 1.15B.
A.I. Advisor
published General Information

General Information

a developer of novel products to prevent and treat infectious diseases

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2100 Powell Street
Phone
+1 510 848-5100
Employees
408
Web
https://www.dynavax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNPSX36.040.45
+1.26%
ProFunds Financials UltraSector Svc
DGYGX40.880.25
+0.62%
BNY Mellon Appreciation Y
PGIEX34.130.18
+0.53%
Putnam Focused Equity C
PEIOX42.230.13
+0.31%
Principal Equity Income R3
WBALX17.100.05
+0.29%
Weitz Conservative Allocation-Inv Cl

DVAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.31%
ACET - DVAX
39%
Loosely correlated
-4.81%
SNDL - DVAX
35%
Loosely correlated
-2.10%
ALKS - DVAX
33%
Poorly correlated
-1.75%
AMRX - DVAX
32%
Poorly correlated
+0.51%
BCRX - DVAX
31%
Poorly correlated
-1.34%
More

Groups containing DVAX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.31%
Pharmaceuticals: Generic
industry (219 stocks)
37%
Loosely correlated
-0.27%